Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
Clinical trial NCT03569293 · COMPLETED
Trial details
- NCT number
- NCT03569293
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-13
- Primary completion
- 2021-01-06
- Enrollment
- 912
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.